OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, has secured £1.8M in seed funding, led by Ahren Innovation Capital and with additional investment from Empirical Ventures, Kadmos Capital and Panacea Investment Group. The funds will support OutSee through the next phase of its growth strategy, with a focus on expanding the Company's in-house target discovery program and establishing new strategic partnerships with leading pharma and biotech companies.